Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Acutus Medical Inc (NQ: AFIB )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, May 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Acutus Medical Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
53 Biggest Movers From Yesterday
Gainers Longeveron Inc. (NASDAQ: LGVN) shares jumped 105.4% to close at $13.80 on Thursday after the company announced the publication of results from a Phase 1 trial testing... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Longeveron (NASDAQ:LGVN) stock rose 60.6% to $10.79 during Thursday's regular session. As of 13:31 EST, this security is trading at a volume of 84.1 million... 
Via Benzinga
Here's Why Acutus Medical Shares Are Falling
Acutus Medical Inc (NASDAQ: AFIB) shares are trading lower by 20.8% at $1.53 after the company reported worse-than-expected fourth-quarter EPS results and issued first-quarter sales guidance below... 
Via Benzinga
Acutus Medical: Q4 Earnings Insights
Acutus Medical (NASDAQ:AFIB) reported its Q4 earnings results on Wednesday, March 30, 2022 at 04:01 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For March 10, 2022
Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares... 
Via Benzinga
5 Stocks To Watch - Thursday, March 31
Some of the stocks that may grab investor focus today. 
Via Talk Markets
Acutus Medical Earnings Perspective: Return On Capital Employed
Acutus Medical (NASDAQ:AFIB) brought in sales totaling $4.36 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 9.66%, resulting in a loss of $31.26 million. 
Via Benzinga
The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Jobless Claims Data
Pre-open movers 
Via Benzinga
5 Stocks To Watch For March 31, 2022
Some of the stocks that may grab investor focus today are: 
Via Benzinga
Earnings Scheduled For March 30, 2022
Companies Reporting Before The Bell • Orgenesis (NASDAQ:ORGS) is likely to report earnings for its fourth quarter. • RumbleON (NASDAQ:RMBL) is estimated to report earnings for its Fiscal Year 2021. 
Via Benzinga
Earnings Outlook For Acutus Medical
Acutus Medical (NASDAQ:AFIB) is set to give its latest quarterly earnings report on Wednesday, 2022-03-30. Here's what investors need to know before the announcement. Analysts estimate that Acutus... 
Via Benzinga
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets. 
Via Benzinga
The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Earnings Scheduled For March 17, 2022
Companies Reporting Before The Bell • TransGlobe Energy (NASDAQ:TGA) is estimated to report earnings for its fourth quarter. • Ikena Oncology (NASDAQ:IKNA) is... 
Via Benzinga
Acutus Medical's Earnings Outlook
Acutus Medical (NASDAQ:AFIB) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Acutus Medical, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AFIB
WHY: New York, NY - (NewMediaWire) - March 15, 2022 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Acutus Medical, Inc. (NASDAQ: AFIB) between May 13, 2021... 
Via NewMediaWire
AFIB INVESTOR NEWS: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Acutus Medical, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action AFIB
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Acutus Medical, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action AFIB
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Investor Action Notice: The Schall Law Firm Encourages Investors in Acutus Medical, Inc. with Losses of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
87 Biggest Movers From Yesterday
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares jumped 150% to close at $3.80 on Wednesday. Sunshine Biopharma, last month, priced its 1.88 million unit uplisting to... 
Via Benzinga
Investor Action Alert: The Schall Law Firm Encourages Investors in Acutus Medical, Inc. with Losses of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Shareholder Action Reminder: The Schall Law Firm Encourages Investors in Acutus Medical, Inc. with Losses of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Investor Action Notice: The Schall Law Firm Encourages Investors in Acutus Medical, Inc. with Losses of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
NASDAQ:AFIB Shareholder Notice: Lawsuit Alleges Securities Laws Violations by Acutus Medical, Inc.
San Diego, CA -- (SBWIRE) -- 02/28/2022 -- An investor, who purchased NASDAQ:AFIB shares, filed a lawsuit against Acutus Medical, Inc. over alleged violations of Federal Securities Laws. 
Via SBWire
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acutus Medical, Inc. (AFIB)
From Glancy Prongay & Murray LLP
Via Business Wire
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acutus Medical, Inc. (AFIB)
From Law Offices of Howard G. Smith
Via Business Wire
Investor Action Notice: The Schall Law Firm Encourages Investors in Acutus Medical, Inc. with Losses of $100,000 to Contact the Firm
Los Angeles - (NewMediaWire) - February 25, 2022 - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acutus Medical, Inc. (“Acutus”... 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Investor Action Notice: The Schall Law Firm Encourages Investors in Acutus Medical, Inc. with Losses of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Acutus Medical, Inc. (AFIB) Investors
From Glancy Prongay & Murray LLP
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.